Home/Filings/4/0001104659-21-048826
4//SEC Filing

Klein Dov 4

Accession 0001104659-21-048826

CIK 0001429260other

Filed

Apr 8, 8:00 PM ET

Accepted

Apr 9, 5:22 PM ET

Size

5.4 KB

Accession

0001104659-21-048826

Insider Transaction Report

Form 4
Period: 2021-01-01
Klein Dov
Director
Transactions
  • Award

    Common Stock, par value $0.001

    2021-01-01+100,000655,000 total
Footnotes (2)
  • [F1]One-third of the shares will vest on each of January 1, 2022, 2023 and 2024, subject to continued service. The reporting person elected to defer 80,000 of these restricted shares pursuant to the issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the reporting person in January of the year following the reporting person's termination of service, or earlier upon his death or change in control of the issuer.
  • [F2]The total holdings include 480,000 shares of deferred restricted stock and 40,000 shares underlying deferred restricted stock units.

Issuer

Fortress Biotech, Inc.

CIK 0001429260

Entity typeother

Related Parties

1
  • filerCIK 0001647971

Filing Metadata

Form type
4
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 5:22 PM ET
Size
5.4 KB